Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Zentalis Pharmaceuticals (ZNTL) Revenue (2024)

Historic Revenue for Zentalis Pharmaceuticals (ZNTL) over the last 1 years, with Q4 2024 value amounting to $26.9 million.

  • Zentalis Pharmaceuticals' Revenue changed N/A to $26.9 million in Q4 2024 from the same period last year, while for Sep 2025 it was $26.9 million, marking a year-over-year decrease of 3376.48%. This contributed to the annual value of $67.4 million for FY2024, which is N/A changed from last year.
  • As of Q4 2024, Zentalis Pharmaceuticals' Revenue stood at $26.9 million.
  • In the past 5 years, Zentalis Pharmaceuticals' Revenue registered a high of $40.6 million during Q1 2024, and its lowest value of $26.9 million during Q4 2024.